I have posted many bearish outlooks on TEVA in Q4 of 2018, especially after price broke below a wedge pattern and therefore signaled bearish continuation. Price action has since continued to confirm the bearish outlook.Teva Pharmaceutical (TEVA) Remains in a New Bearish ChannelTeva Pharmaceutical (TEVA) - Broken Wedge Support Tested as ResistanceAfter a recovery in January, price action is again signaling bearish continuation.TEVA Daily Chart(click to enlarge)Respecting Resistance:- We can see on the daily chart that after price came up to $20 in January, it stalled. - This area represented a previous support area, as well as the cluster of the 200- , 100-, and 50-day simple moving averages (SMAs). - Essentially, TEVA respected a previous support area and the 200-day SMA as resistance, which is a bearish sign. - It fell sharply during the 2/13 session, further confirmation the turnaround here. - Note that the fall at the moment is faster than the rally since late December through January .- This price action suggests downside to at least test the previous support in the $14.60-$15 area. - If price indeed falls to $14.60, I would not rely on it as support. - The $11 low from 2017 is still in sight, though we can anticipate some support there, maybe even a little higher, around $12.